Advanced Medical Solutions Group plc

Advanced Medical Solutions Group plc (AMS) is a world-leading independent developer and manufacturer of innovative tissue-healing technologies serving surgical, wound care, and specialty medical markets globally. The company operates 14 manufacturing and R&D locations across Europe, Asia, and other regions, with >1,500 employees and distribution partnerships in >90 countries. Core product lines include: (1) Surgical—adhesives and sealants for internal wound closure, biosurgicals (collagen-based hemostats and regenerative products), and sutures and related supplies; (2) Wound Care—exudate management systems, infection control dressings, and other advanced wound technologies including hydrogels. AMS also operates a dental division and contract manufacturing services. Key subsidiary and acquired brands include RESORBA (biosurgicals and sutures, Nürnberg and Domazlice), Raleigh Adhesive Coatings (woundcare coatings, Stafford), ActivHeal (wound care brand), Peters Surgical (clips and sutures, Domalain France; suture manufacturing in Thailand and India), Catgut GmbH (sutures, Markneukirchen), and Connexicon Medical (tissue adhesives R&D, Dublin). Manufacturing capabilities span bulk foam roll-stock, collagen processing, suture extrusion, and specialized coatings and formulations. The company is listed on the London Stock Exchange (LSE), with FY24 revenue of £177.5M and adjusted profit of £29.4M. Regulatory standing implies FDA, ISO 13485, and CE mark compliance across product portfolio, though specific certifications are not detailed on fetched pages. AMS positions itself as a surgical powerhouse and leader in tissue regeneration and hemostasis.